Startup Envisagenics Nabs NIH Grant to Develop Alternative Splicing Analysis Tech

Aug 13, 2015

|

Premium

NEW YORK (GenomeWeb) – Just weeks after securing $100,000 in seed financing, bioinformatics startup Envisagenics has been awarded $225,000 grant from the National Institutes of Health to create a prototype of its core technology — a cloud-based platform for the detection, quantification, and interpretation of alternative splicing (AS) variation from next-generation sequencing data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Collins to Avoid 'Manels'

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Patient Dies Following Fecal Transplant

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

From Pigs to Monkeys

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

This Week in Science

In Science this week: almond reference genome, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

BlueBee Data Security & Compliance

Whole Genome Sequencing of Microbial Communities for Scaling Microbiome and Metagenomic Studies

NGS is Accelerating Therapeutic Antibody Discovery - What Lies Beyond?

Jun

17

Featured Webinar

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Menu